EUVIMEDEUVIMED entdecken
Crossref

RAD21-mediated epigenetic regulation promotes lung adenocarcinoma progression and sensitizes cancer cells to ERK-targeted therapy

Chu Xiao, Tao Fan, Di Wang, Hongfei Yin, Ziqin Deng, Wenpeng Cai, Yu Ji, Yixiao Liu, Jia Li, Tianle Liao, Chunxiang Li, Jie He

Cancer Letters · 2025

DOI: 10.1016/j.canlet.2025.218062 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Letters, 2025. Verfasst von Chu Xiao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Scien…. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms, Epigenesis, Genetic, Nuclear Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Beijing Natural Science Foundation, Chinese Academy of Medical Sciences Initiative for Innovative Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The cohesin complex, a critical chromatin organizer and transcriptional regulator, is pivotal in oncogenesis. In lung adenocarcinoma (LUAD), its core subunit RAD21 is frequently amplified and overexpressed. However, its functional mechanisms and potential in targeted-therapy improvement remain elusive. Here, survival analysis and immunohistochemistry revealed that high RAD21 protein levels correlate with poor patient prognosis. Genetic depletion of RAD21 suppressed LUAD cell proliferation by inducing cell cycle arrest and apoptosis, while significantly reducing metastatic capacity both in vitro and in vivo. Integrated transcriptome sequencing (RNA-seq) and chromatin immunoprecipitation sequencing (ChIP-seq) analysis demonstrated that RAD21 occupies genomic regions of genes linked to MAPK signaling and metastasis. RAD21 depletion repressed epithelial-mesenchymal transition (EMT), focal adhesion, and MAPK/ERK cascade activation. RAD21 further modulated H3K4me3 chromatin modification, inducing widespread transcriptional dysregulation of cancer-associated genes. Pharmacological ERK inhibition with ulixertinib effectively reversed RAD21-driven metastasis, particularly in KRAS-mutant contexts. Our findings establish RAD21-mediated epigenetic regulation as a novel mechanism driving LUAD progression. The efficacy of ulixertinib in suppressing cancer metastasis in preclinical models highlights its translational potential for LUAD therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungLung NeoplasmsEpigenesis, GeneticNuclear ProteinsHumansAnimalsMiceGene Expression Regulation, NeoplasticCell Line, TumorCell ProliferationMAP Kinase Signaling SystemDisease ProgressionEpithelial-Mesenchymal TransitionXenograft Model Antitumor AssaysApoptosisDNA-Binding ProteinsCell Cycle Proteins

Stichwörter der Autor:innen

CohesinERKLung adenocarcinomaRAD21Ulixertinib

Substanzen

RAD21 protein, humanNuclear ProteinsDNA-Binding ProteinsCell Cycle Proteins

Autor:innen und Institutionen

  • Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China.
  • Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China; Departme…
  • Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China; 4+4 Medi…
  • Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100021, China. Electron…

Förderung

  • National Natural Science Foundation of China
  • Beijing Natural Science Foundation
  • Chinese Academy of Medical Sciences Initiative for Innovative Medicine

Zitieren

APA

Xiao, C., Fan, T., Wang, D., Yin, H., Deng, Z., Cai, W., Ji, Y., Liu, Y., Li, J., Liao, T., Li, C., & He, J. (2025). RAD21-mediated epigenetic regulation promotes lung adenocarcinoma progression and sensitizes cancer cells to ERK-targeted therapy. Cancer Letters. https://doi.org/10.1016/j.canlet.2025.218062

Vancouver

Xiao C, Fan T, Wang D, Yin H, Deng Z, Cai W, et al. RAD21-mediated epigenetic regulation promotes lung adenocarcinoma progression and sensitizes cancer cells to ERK-targeted therapy. Cancer Letters. 2025. doi:10.1016/j.canlet.2025.218062

BibTeX
@article{Xiao2025,
  author = {Xiao, Chu and Fan, Tao and Wang, Di and Yin, Hongfei and Deng, Ziqin and Cai, Wenpeng and Ji, Yu and Liu, Yixiao and Li, Jia and Liao, Tianle and Li, Chunxiang and He, Jie},
  title = {RAD21-mediated epigenetic regulation promotes lung adenocarcinoma progression and sensitizes cancer cells to ERK-targeted therapy},
  journal = {Cancer Letters},
  year = {2025},
  doi = {10.1016/j.canlet.2025.218062}
}
Kostenlos starten →